NICO Holdings plc (MAL:NICO)

Intra-Cellular Therapies Revenue

In the year 2024, NICO Holdings had annual revenue of 503.94B MWK with 73.50% growth. NICO Holdings had revenue of 299.28B in the half year ending December 31, 2024, with 99.86% growth.

• Revenue: 503.94B
• Revenue Growth: +73.50%
• P/S Ratio: 2.06
• Revenue / Employee: 392.48M
• Employees: 1,284
• Market Cap: 1,037.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	503.94B	213.48B	73.50%
Dec 31, 2023	290.47B	85.14B	41.46%
Dec 31, 2022	205.33B	-7.36B	-3.46%
Dec 31, 2021	212.69B	43.68B	25.84%
Dec 31, 2020	169.01B	28.50B	20.28%